# Chronic, Low Dose Erythropoetin Beta in Ischemic Cardiomyopathy

> **NCT00568542** · PHASE4 · COMPLETED · sponsor: **Charite University, Berlin, Germany** · enrollment: 28 (actual)

## Conditions studied

- Ischemic Cardiomyopathy

## Interventions

- **DRUG:** erythropoetin beta
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00568542
- **Lead sponsor:** Charite University, Berlin, Germany
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2009-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00568542

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00568542, "Chronic, Low Dose Erythropoetin Beta in Ischemic Cardiomyopathy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00568542. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*